STAT

NOVEMBER 14, 2024

Measles vaccination coverage globally has still not recovered to pre-Covid levels, a fact that contributed to a 20% increase in measles cases in 2023 over the previous year, according to a new report from the World Health Organization and the Centers for Disease Control and Prevention that was released Thursday. The pandemic backsliding is hindering efforts to eliminate measles globally, and subjecting children — generally children under the age of 5 — to a health threat that can b

Vaccines 364

Vaccines 364

PharmaVoice

NOVEMBER 14, 2024

While Martin Shkreli smirked his way through a public securities fraud investigation, Ron Tilles became interim CEO of Turing Pharmaceuticals, ready or not. Here’s his story.

130

130

STAT

NOVEMBER 14, 2024

WASHINGTON — Peter Marks wants to keep his job. A top Food and Drug Administration official, Marks arrived Wednesday at the five-star hotel where the Milken Institute was hosting its Future of Health Summit via bicycle, having flown back to D.C. from Boston, where he spoke earlier in the day. In a black suit jacket and moccasins, he looked slightly nervous on a six-person panel.

Vaccines 363

Vaccines 363

Safe Biologics

NOVEMBER 14, 2024

SAVE THE DATE: ASBM and GaBI to Present Webinar on the Biosimilar Red Tape Elimination Act October 31st On October 31st, ASBM and the Generics and Biosimilar Initiative will present a webinar focusing Senate Bill 2305, the Biosimilar Red Tape Elimination Act. Health policy experts will review current U.S. biosimilar approval and substitution policies, discuss the rationale behind them, and examine the potential consequences of the proposed changes.

Biosimilars 130

Biosimilars 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 14, 2024

After turning cystic fibrosis from a death sentence into a manageable condition for many patients, Vertex Pharmaceuticals is now looking to transform the treatment of pain, and a pivotal point in this quest is fast approaching. The Boston biotech plans to announce results by the end of the year from a mid-stage trial of an experimental treatment for patients with lumbosacral radiculopathy, or LSR, more commonly known as sciatica.

Drug Development 333

Drug Development 333

Express Pharma

NOVEMBER 14, 2024

On the heels of World Prematurity Day, AstraZeneca Pharma India announces a strategic collaboration with the Indian Academy of Paediatrics. The two organisations have come together to raise awareness on RSV (Respiratory Syncytial Virus) that can put newborn pre-term babies at risk of respiratory illnesses and the need for timely intervention thereof.

Immunity 101

Immunity Immunization 101

Express Pharma

NOVEMBER 14, 2024

Cadila Pharmaceuticals has launched Militol, an iron supplement designed to provide a precise combination of nutrients that maximise absorption and enhance tolerance, effectively addressing iron deficiency. Militol’s supplements contain ferric maltol, a low-dose form of ferric iron complexed with maltol. It also includes folic acid to promote red blood cell production, vitamin B12 for neurological health and red blood cell formation, vitamin C to enhance iron absorption and support immune health

Immunity 102

Immunity Immunization 102

STAT

NOVEMBER 14, 2024

The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceutical company to task for its marketing. The regulator criticized Merz for a few reasons concerning Xeomin, which is promoted as an alternative to Botox for combating wrinkle and frown lines.

Pharmaceutical Companies 293

Pharmaceutical Companies Pharmaceutical Companies 293

Pharmaceutical Technology

NOVEMBER 14, 2024

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a programmed death-ligand 1 and vascular endothelial growth factor A-targeting bispecific antibody.

98

98

STAT

NOVEMBER 14, 2024

LONDON — Reversing an earlier decision, European regulators on Thursday recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved, saying that the benefits of the treatment outweigh the risks in a select group of patients. A European Medicines Agency committee had said in July that the medicine, called Leqembi, should be rejected, citing the modest benefits seen in trials and the potentially dangerous side effects that accompany the drug.

306

306

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

NOVEMBER 14, 2024

The government has urged pharmacies to work with ministers to achieve 'a service fit for the future', following a vote by pharmacy owners in favour of collective action. The Department of Health and Social Care said it was 'committed to working with the sector and would encourage all pharmacists to work with us'. This comes […] The post Government encourages pharmacists to 'work with us' appeared first on The Pharmacist.

98

98

STAT

NOVEMBER 14, 2024

As a medical intern in the late 1980s, I’d occasionally see priests and rabbis on hospital wards, but we basically ignored one another. When we doctors walked into a patient’s room, they’d quickly leave, and when we exited, they’d enter. They seemed to operate in a wholly different realm. After all, we were scientific.

Hospitals 278

Hospitals 278

pharmaphorum

NOVEMBER 14, 2024

There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn't left behind. Its solution is a licensing deal with Chinese biotech LaNova Medicines for LM-299, which consists of an anti-VEGF antibody joined to the functional parts of a pair of anti-PD-1 antibodies.

72

72

STAT

NOVEMBER 14, 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it’s a good time to correct one of the more egregious misconceptions regarding the handling of patient subgroup data that has been floating persistently around the internet.

289

289

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 14, 2024

GSK's multiple myeloma therapy Blenrep's increase in overall survival in the DREAMM-7 trial has achieved statistical significance

99

99

STAT

NOVEMBER 14, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning, my dear subscribers. This is my last Readout newsletter — just kidding! It’s just my last Readout for the next few weeks. I’m going off on a three-week vacation and so you won’t see my name here for a while.

Drug Pricing 268

Drug Pricing Drug Development 268

The Pharmacist

NOVEMBER 14, 2024

Community pharmacy leaders across the sector have called for uplifted funding to stop pharmacy closures and ease pressures, stressing that the current arrangements are putting patient safety at risk. This comes as the National Pharmacy Association (NPA) announced that 99% of participating pharmacy owners voted to limit their services unless funding is improved.

Community Pharmacies 85

Community Pharmacies 85

STAT

NOVEMBER 14, 2024

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from LaNova Medicines, a Shanghai-based firm, for $588 million upfront and as much as $2.7 billion in potential milestone payments. The cancer immunotherapy Keytruda, Merck’s most important product and the best-selling drug in the world with $23 billion in annual sales, is set to lose patent protection and face competition from generic drugmakers as early as 2028,

Research Laboratories 286

Research Laboratories Drug Development 286

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Patent Watch

NOVEMBER 14, 2024

The pharmaceutical industry has undergone significant transformations in recent years, with the increasing complexity of clinical trials and the need for cost and time efficiency driving the growth of contract research organizations (CROs).

Drug Development 83

Drug Development 83

STAT

NOVEMBER 14, 2024

You’re probably not worried about the role that Strava is playing in the teen mental health crisis. But you should be. Strava seems extremely benign — especially compared to an app like Instagram or TikTok. It simply “lets you track your running and riding with GPS, join Challenges, share photos from your activities, and follow friends,” in the company’s own words.

232

232

pharmaphorum

NOVEMBER 14, 2024

Syncona launches Slingshot Therapeutics with a mission to find promising projects in academia and translate them into development projects.

91

91

STAT

NOVEMBER 14, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning. I’m back on the newsletter beat today while Theresa’s on holiday, but I’m off to Chicago soon to cover the American Heart Association’s scientific sessions. Ping me if you’ll be following the conference, too.

251

251

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 14, 2024

If any further evidence were needed for the insatiable investor appetite for companies with obesity assets, look no further than New York startup Metsera.After emerging from stealth with a $290 million first round in April, the biotech has added another $215 million to its coffers via a Series B led by Wellington Management and Venrock Healthcare Capital Partners, taking the total raised by the company over $500 million in just seven months.

76

76

STAT

NOVEMBER 14, 2024

Rise and shine, everyone, another busy day is on the way. We can tell by the sound of the motor vehicles passing by our window and the furious panting of the official mascots as they forage for breakfast on the campus grounds. Even Mrs. Pharmalot is up and about earlier than usual thanks to her own hectic agenda. As for us, we are engaged in the usual ritual of brewing cups of stimulation.

253

253

Outsourcing Pharma

NOVEMBER 14, 2024

Pharmacokinetic (PK) tests form an integral part of the drug development process, helping to ensure the safety and efficacy of new drugs.

Drug Development 88

Drug Development 88

STAT

NOVEMBER 14, 2024

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company shuts down, and a deep dive on digital measures for tracking disease.

202

202

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

NOVEMBER 14, 2024

The company is paying China-based biotech LaNova Medicines $588 million for the type of dual-pronged antibody drug that recently bested Keytruda in a clinical trial.

74

74

STAT

NOVEMBER 14, 2024

Why are AbbVie executives feeling the M&A blues? What does it take to slice $12 billion from Amgen’s market value? And why are STAT’s D.C. correspondents working so hard?  We talk about all that and more on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. It’s a “Chatty Cathy” episode!

162

162

BioPharma Dive

NOVEMBER 14, 2024

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

74

74

Pharma Times

NOVEMBER 14, 2024

Therapy shows high efficacy in initial trial phase

Immunity 115

Immunity Immunization 115

Outsourcing Pharma

NOVEMBER 14, 2024

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.

67

67